Evaluation of the incidence and of risk factors associated with trastuzumab-associated cardiac toxicity in routine clinical practice

被引：0
|
作者：
Lemieux, J. [1 ]
Cote, M. [1 ]
Provencher, L. [1 ]
Simard, I. [1 ]
St-Pierre, C. [1 ]
Demers, E. [1 ]
机构：
[1] Univ Quebec, Affiliated Hosp Ctr, Quebec City, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
589
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Trastuzumab-associated cardiac dysfunction.
    Singh, D
    Burns, RL
    Silverman, P
    Cooper, BW
    Krishnamurthi, S
    Fu, P
    Overmoyer, BA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 77S - 77S
  • [2] Trastuzumab-associated peripheral vascular toxicity
    Pansegrau, Gary K.
    Grant, Dennis R.
    Norris, Brian
    Gelmon, Karen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1438 - 1440
  • [3] Cardiac toxicity associated to trastuzumab treatment in usual clinical practice
    Gallego Page, J. C. Juan Carlos
    Gallego Sanchez, G.
    Gomez Perez, A.
    Salas Nieto, J.
    Portero Portaz, J. J.
    Lafuente Gormaz, C.
    Aguilera Saldana, M.
    Aliaga, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 71 - 71
  • [4] Trastuzumab-associated cardiac events in the Persephone trial
    Helena M Earl
    Anne-Laure Vallier
    Janet Dunn
    Shrushma Loi
    Emma Ogburn
    Karen McAdam
    Luke Hughes-Davies
    Adrian Harnett
    Jean Abraham
    Andrew Wardley
    David A Cameron
    David Miles
    Ioannis Gounaris
    Chris Plummer
    Louise Hiller
    British Journal of Cancer, 2016, 115 : 1462 - 1470
  • [5] Trastuzumab-associated cardiac events in the Persephone trial
    Earl, Helena M.
    Vallier, Anne-Laure
    Dunn, Janet
    Loi, Shrushma
    Ogburn, Emma
    McAdam, Karen
    Hughes-Davies, Luke
    Harnett, Adrian
    Abraham, Jean
    Wardley, Andrew
    Cameron, David A.
    Miles, David
    Gounaris, Ioannis
    Plummer, Chris
    Hiller, Louise
    BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1462 - 1470
  • [6] Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    Suter, Thomas M.
    Procter, Marion
    van Veldhuisen, Dirk J.
    Muscholl, Michael
    Bergh, Jonas
    Carlomagno, Chiara
    Perren, Timothy
    Passalacqua, Rodolfo
    Bighin, Claudia
    Klijn, Jan G. M.
    Ageev, Fail T.
    Hitre, Erika
    Groetz, Juergen
    Iwata, Hiroji
    Knap, Malgorzata
    Gnant, Michael
    Muehlbauer, Susanne
    Spence, Alison
    Gelber, Richard D.
    Piccart-Gebhart, Martine J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3859 - 3865
  • [7] Assessment of Adjuvant Trastuzumab-Associated Cardiac Toxicity in Korean Patients with Breast Cancer: A Single-Center Analysis
    Cha, Chihwan
    Ahn, Sung Gwe
    Lee, Hak Min
    Lee, Hak Woo
    Lee, Seung Ah
    Jeong, Joon
    ONCOLOGY, 2013, 85 (04) : 228 - 234
  • [8] Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction
    Beer, Lynn A.
    Kossenkov, Andrew V.
    Liu, Qin
    Prak, Eline Luning
    Domchek, Susan
    Speicher, David W.
    Ky, Bonnie
    CIRCULATION RESEARCH, 2016, 119 (10) : 1135 - 1144
  • [9] Pattern of Cardiac Monitoring and Risk of Trastuzumab Associated-Cardiac Dysfunction in a Clinical Practice: A Population Based Study.
    Lee-Ying, R.
    Ubhi, C.
    Roberts, S.
    Lim, H.
    Bhatt, H.
    Gesy, K.
    Ahmed, S.
    CANCER RESEARCH, 2011, 71
  • [10] An Unusual Pulmonary Infiltrate: Considering Trastuzumab-Associated Pulmonary Toxicity in a Post-Surgical Cancer Patient
    Sadeq, Z.
    Yuan, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S34 - S34
12345